Inventor · disambiguated record
Rajay Pandit
Also filed as: PANDIT RAJAY A · Pandit Rajay
10 granted patents·7 pending applications·9 citations·filing 2017–2025
82Inventor score
Top patents by PatentIndex Score
17 records- 0188US10501551B2Multivalent and multispecific 41BB-binding fusion proteinsINHIBRX INC·Filed 2017·Granted Dec 10, 2019·7 cites·64 claims
- 0284US11117972B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0384US2025250349A1Uses of pdl1-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0481US12297271B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted May 13, 2025·0 cites·18 claims
- 0581US12187804B2Multivalent and multispecific 41BB-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2022·Granted Jan 7, 2025·0 cites·12 claims
- 0675US2025092137A1Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0772US12227584B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX BIOSCIENCES INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 0872US11945869B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2021·Granted Apr 2, 2024·0 cites·17 claims
- 0972US11208485B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2019·Granted Dec 28, 2021·0 cites·28 claims
- 1071US11566078B2PDL1-binding proteinsINHIBRX INC·Filed 2019·Granted Jan 31, 2023·0 cites·22 claims
- 1163US2025313623A1Dll3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1261US12365728B2DLL3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jul 22, 2025·0 cites·32 claims
- 1359US12195533B2Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jan 14, 2025·0 cites·27 claims
- 1458US2024376198A1NKp46-Targeted Modified IL-2 Polypeptides and Uses ThereofINHIBRX INC·Filed 2022·Application pending·0 cites
- 1558US2025136681A1NKp46-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1655US2023331846A1Canine PD-1-Binding Polypeptides and Uses ThereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 1749US2017198051A1Multivalent and multispecific ox40-binding fusion proteinsINHIBRX LP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajay Pandit files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →